Market Research Blog – Page 1139 – New Product Development

Manometry Systems Market Expected to Reach USD 311.64 Million by 2033, Growing at a CAGR of 5.4%

The global manometry systems market is on a positive growth trajectory, with sales reaching approximately USD 184.18 million in 2023. The market is projected to expand at a compound annual growth rate (CAGR) of 5.4%, ultimately reaching a valuation of USD 311.64 million by 2033.

Manometry systems are essential diagnostic tools used to evaluate the function of muscles and nerves in the digestive tract, particularly in the assessment of conditions such as fecal incontinence and constipation. The growing awareness and need for accurate diagnostic methods are propelling the demand for these systems across the healthcare sector.

This phenomenal expansion is being driven by several significant variables influencing the landscape of the manometry system business. A large increase in the incidence of fecal incontinence and constipation, combined with an aging worldwide population, is driving the market’s increasing trend. Furthermore, continuing technical developments and ongoing healthcare infrastructure development are critical to the industry’s success.

The surge in cases related to constipation, fecal incontinence, anorectal pain, pelvic floor dyssynergia, and Hirschsprung’s among the elderly population is fueling the adoption of manometry systems. The increasing demand for these systems stems from their ability to evaluate patients, providing valuable data on anorectal function and indicating the prognosis of treatment, especially in managing sphincter injuries.

Rising demand for non-invasive equipment is driving the demand for manometry systems. These systems are non-invasive diagnostic procedures that can detect pressures and sensations in the anus and rectum. With this, they indicate whether the patient’s pelvic function is normal without incision into the body or removal of tissue and has low risks, and complications.

Further, rising government initiatives and funding supporting the development of products are boosting the demand for the Global Manometry System Industry. Initiatives undertaken by the government to enable and boost the ecosystem for the indigenous medical device industry are also stimulating market growth.

“As demand for manometry systems is rising due to high prevalence of gastrointestinal diseases, key players are engaging in product development that is technologically advanced for faster approvals. This is expected to give the key players a competitive edge in the industry, generating revenues,” says the FMI Analyst

Key Takeaways from the Manometry System Market Study

By product, system sheaths & catheters are expected to account for the largest share of 0% in 2021.
In terms of portability, the stand-alone system will hold the largest share of 4 in 2021 on the back of its enhanced sensitivity to provide accurate diagnosis of the condition
By end user, hospitals accounted for the largest share of 9 in 2021 owing to the rising demand for hospital stays that is short-term and an increasing number of gastrointestinal processes.
North America is expected to hold the largest share of 38.9% in 2021 with the U.S. leading the market during the forecast period.

For instance,

In October 2021, “UROTECH GmbH subsidiary of Medi-Globe Group provided detailed information on a new clinical study for using the Magnetic Black-Star® (MBS) in pediatric urology. The MBS was an innovative product of UROTECH GmbH, which is used in stent placement as well as stent removal of children without performing the surgeries using the stent’ magnetic tip.”
In May 2020, RMS Medical Devices proudly announced its acquisition of QUICKORE products for BENELUX. With this new acquisition, RMS Medical Devices adds another premium technology to its Radiology portfolio.
In October 2020, LABORIE Medical Technologies entered into a strategic partnership with Urotronic to support regulatory approval of Optilume, a drug-coated balloon (DCB) technology for use in urethral strictures and benign prostatic hyperplasia (BPH).
In August 2021, Medtronic Announced the FDA Approval of the Next-Gen TAVR System for the treatment of symptomatic severe aortic stenosis. Next-Gen TAVR System is a self-expanding transcatheter aortic valve replacement, which is designed to enhance ease of use and predictable valve deployment throughout the procedure.

The key market players covered by FMI include EB Neuro S.p.A, MEDSPIRA, Medtronic, Medica S.p.A., RMS Medical Devices, MARQUAT Génie Biomédical, Diversatek Inc., Dentsleeve International Ltd., LABORIE, Prometheus Group, Smart Medical Group, Synectics Medical Limited, Medovations Inc., Sierra Scientific, and Urotech Gmbh.

Key Segments of the Manometry System Market by Category

Product:

Anorectal Manometry System
Anorectal Manometry System Software
Anorectal Manometry System Sheath & Catheters

Portability:

Stand Alone System
Portable System

End User:

Hospitals
Diagnostic Centers
Specialty Clinics
Academic Research Institutes

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Nasal Antihistamines Market Projected to Reach USD 3.23 Billion by 2023, Anticipating Growth of 4.6% CAGR Through 2033

The global nasal antihistamines market is poised for significant growth, projected to attain a value of approximately USD 2.06 billion by the end of 2023. With a robust compound annual growth rate (CAGR) of 4.6%, sales of nasal antihistamines are anticipated to reach a noteworthy USD 3.23 billion by 2033.

Nasal antihistamines are a popular choice for allergy relief, providing effective treatment for symptoms such as sneezing, runny nose, and itchy eyes. Their ability to deliver quick relief and minimize the side effects commonly associated with oral antihistamines makes them increasingly preferred among consumers.

Key Market Drivers:

Rising Allergy Incidence: The growing prevalence of allergic rhinitis and other respiratory allergies worldwide is driving the demand for nasal antihistamines. As more individuals seek effective solutions to manage their symptoms, the market is expected to expand.
Innovative Product Developments: Ongoing research and development efforts are leading to the introduction of new and improved nasal antihistamine formulations. These advancements are expected to enhance patient adherence and expand the consumer base.
Consumer Awareness and Accessibility: Increased awareness regarding allergy management and the availability of over-the-counter nasal antihistamines are contributing to the market’s growth. Consumers are becoming more proactive in seeking effective treatments for their allergy symptoms.

The nasal antihistamines market is well-positioned for substantial growth as it responds to the rising demand for effective allergy relief solutions. With ongoing innovations and an expanding consumer base, the market offers ample opportunities for stakeholders to engage and succeed.

Antihistamines, renowned for their effectiveness in alleviating allergy symptoms, have become a focal point in the pharmaceutical landscape. These medications play a pivotal role in addressing issues stemming from an excess of histamine—a natural substance produced by the immune system. Individuals suffering from allergies, particularly those triggered by pollen and various allergens, have wholeheartedly embraced antihistamines to find relief from symptoms such as sneezing, congestion, and itchy, runny noses.

Over the past three decades, the global prevalence of respiratory diseases—including allergic rhinitis, chronic obstructive pulmonary disease, and asthma—has surged. According to a report published by the National Center for Biotechnology Information (NCBI), approximately 20–30% of the Indian population grapples with allergic rhinitis, with 15% eventually developing asthma¹.

Due to this growing burden, there has been an increased adoption rate of nasal antihistamines in the form of nasal sprays and nasal drops, globally. The nasal antihistamines provide rapid and effective relief from the symptoms of allergic rhinitis. Thus, the growing number of allergic rhinitis cases will propel the growth of the Global Nasal Antihistamines Industry in the future.

Advancements in the field of nasal drug delivery have enabled the establishment of several non-invasive approaches for treatment. Various new products such as metered dose delivery systems, innovative odorless powders and sprays, preservative-free nasal sprays, and others are key drivers that will expand this industry in the forecast period.

FDA approvals of various nasal sprays to switch from prescription to OTC use have led to increased independence concerning the self-administration of drugs, among patients who suffer from allergic rhinitis. Various additions by the manufacturers to the already available product lines, especially for AR are some of the techniques used by the manufacturers to increase product penetration amongst the population.

New product launches & approvals have emerged as key growth strategies adopted by the leading players in the Global Nasal Antihistamines Industry. Following this, the acquisition was the second most key strategy adopted by the industry players. By adopting these strategies, it helped the company to expand its regional presence as well as product offerings.

For instance, In December 2020, GlaxoSmithKline launched Otrivin Breathe Clean, a saline wash with the moisturizing benefit of natural glycerine as a product for the symptomatic relief of allergic rhinitis.

Such developments not only strengthen the company’s existing portfolio but also help to increase their presence at the regional as well as global level, and help companies to sustain the increasing competitive pressure.

Key Takeaways from Nasal Antihistamines Market Study

By product, nasal sprays accounted for the largest share of 89.0% in 2021 and are expected to continue to grow at the same trend during the forecast period.
By age group, adults accounted for the largest share in 2021 of the nasal antihistamines market and are expected to continue to grow at the same trend during the forecast period.
By distribution channel, the retail pharmacies segment is expected to account for the largest share of 41.0% in 2021 of the nasal antihistamines market and is expected to continue to grow at the same trend during the forecast period.
By region, East Asia held 23.0% in 2021 of the nasal antihistamines market. The growing awareness regarding allergies and developing healthcare infrastructure are some factors fueling this region’s high market share.

Nasal Antihistamines Market by Category Product:

Nasal Spray
Nasal Drops

Age Group:

Adult
Pediatric

Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Stores

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Headspace Gas Analyzers Market Set to Surpass USD 179.88 Million by 2023, Projected to Grow at 8.5% CAGR Through 2033

The global headspace gas analyzers market is poised for remarkable growth, with projections indicating that it will exceed USD 77.66 million by the end of 2023. This upward trajectory is expected to continue, as the market is forecasted to achieve a substantial compound annual growth rate (CAGR) of 8.5% through 2033, ultimately reaching an estimated value of USD 179.88 million.

Headspace gas analyzers play a crucial role in various industries, including food and beverage, pharmaceuticals, and environmental monitoring. These instruments are essential for assessing the quality and safety of products by measuring the concentration of gases in the headspace of containers.

Key Market Drivers:

Increased Demand for Quality Control: As industries continue to prioritize product quality and safety, the demand for headspace gas analyzers is expected to rise. These analyzers provide accurate measurements that help ensure compliance with industry standards and regulations.
Technological Advancements: Continuous advancements in analytical technologies are enhancing the efficiency and accuracy of headspace gas analysis. Innovative features such as automated sampling and real-time monitoring are driving adoption across various sectors.
Growing Applications Across Industries: The versatility of headspace gas analyzers is contributing to their widespread adoption. Industries such as pharmaceuticals and food processing rely on these instruments for quality assurance and to extend shelf life, leading to increased market growth.

The headspace gas analyzers market is on track for significant expansion as businesses recognize the importance of accurate gas analysis in maintaining product quality and compliance. With a strong focus on innovation and technological advancements, stakeholders have ample opportunities to engage in this dynamic market.

The growth of the headspace gas analyzers market is primarily driven by the increasing demand for rapid and non-destructive moisture determination of sterile freeze-dried products. The advanced capabilities of headspace gas analyzers provide a swift, non-destructive alternative to traditional moisture analysis methods, significantly enhancing efficiency in quality control processes.

This technological advancement is streamlining moisture analysis efforts across various industries, contributing to the robust expansion of the market. As the need for precise and efficient moisture analysis continues to rise, the headspace gas analyzers market is poised for continued growth and innovation.

All the drawbacks of destructive inspections are eliminated by headspace gas analyzer techniques, allowing a focused, unbiased evaluation of the entire production process to ensure product stability.

Additionally, they provide sterility throughout the entire life cycle of the product, research and validation, routine manufacturing, and the marketing environment. Because of this, if the rules governing their use are changed, the demand for headspace gas analyzers in the pharmaceutical industry and other industries is likely to increase.

The leading manufacturers of headspace gas analyzers have made technological advancement, new product introductions, and regulatory approvals key growth strategies. By employing these tactics, businesses aim to expand both their regional presence and their product offerings.

For instance, the CCI laboratory tester NEO DPX by WILCO AG received the Good Design Award 2020 in the industrial category in July 2021 from the Chicago Athenaeum Museum of Architecture and Design.

For the visual inspection of parenteralia in various packaging materials, WILCO AG developed a customised system design in six phases in June 2019 to ensure the highest level of reliability for the inspection results.

Such developments strengthen the company’s current portfolio, increase their visibility on a regional and international level, and give them the ability to withstand the increasing competitive pressure.

Key Takeaways from Global Headspace Gas Analyzers Industry Study

By product, oxygen headspace analyzers will hold maximum share of more than 45% in 2021.
In terms of modality, benchtop system of headspace gas analyzers are expected to account for over 60% of the market share in 2021 owing to the extreme stability and accuracy in the inspection of overfilled containers with limited headspace.
By end user, the hospitals will account for over 40% of the market share in 2021 owing to the rising demand for sterile products and increasing percentage of health problems by unhygienic food packaging.
North America is expected to hold nearly 40% of global market share in 2021 on the back of rising product adoption, increasing demand for packaging of pharmaceutical products, health consciousness, and increasing disposable incomes

Who is Winning?

Some of the leading manufacturers of Global Headspace Gas Analyzers Industry are focusing on product launch, collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

In June 2021, CS Analytical Laboratory installed LIGHTHOUSE’s Instruments Suite with laser-based headspace capabilities for container closure integrity testing.
In July 2019, Labthink launched a commemorative innovative product, C130H Gas Permeation Test System, a high-precision laboratory testing instrument based on a differential pressure method, to help realize gas permeability, solubility coefficient, and diffusion of thin films and sheets in fields of scientific research, food, pharmaceuticals, packaging materials, and many others, to efficiently enhance product quality control and new product R&D processes.

In July 2017, Illinois Instruments collaborated with OxySense, a leading brand in non-invasive optical oxygen analyzers and permeation testing solutions. OxySense and Systech Illinois had been trusted for decades for delivering the highest quality and most reliable gas measurement solutions.

The key market players covered by FMI include WILCO AG, Quantek Instruments Inc., Illinois Instruments Inc., Labthink International Inc., LIGHTHOUSE, GASPOROX AB, Xepics SA, Bonfiglioli Engineering S.r.l.

A Full Report Analysis Click Here

Global Headspace Gas Analyzers Industry by Category

Product:

Oxygen Headspace Analyzers
Carbon Dioxide (CO2) Headspace Analyzers
Combination Headspace Analyzers
Pressure/Moisture Headspace Analyzers

Modality:

Benchtop Systems
Handheld Headspace Analyzer

End User:

Research & Development Facilities
Contract Manufacturing Organizations
Pharmaceuticals Manufacturing
Clinical Trials Agencies

Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Needle-Free Injectors Market Projected to Surpass USD 42.79 Billion at 12% CAGR of 2032

The global needle-free injectors market will experience substantial growth at an impressive 12% Compound Annual Growth Rate (CAGR) between 2022 and 2032. By the conclusion of this evaluation period, the market is anticipated to reach a valuation of approximately USD 42.79 Billion.

This remarkable growth is primarily attributed to the increasing demand for faster drug delivery, serving as a pivotal driver for the needle-free injector market. Furthermore, the burgeoning healthcare sector and the rising popularity of cosmetic surgeries are contributing significantly to the heightened demand for needle-free injectors.

Notably, between 2017 and 2021, the industry demonstrated substantial growth, achieving a noteworthy value CAGR of 8%, culminating in a market value of USD 12.3 Billion. The utilization of advanced spring-loaded jet injectors has been a key factor propelling market growth. Moreover, the approvals granted by government authorities to expand the utilization of needle-free injectors are further expediting the market’s demand.

Geographically, US is the largest contributor to the needle-free injectors market. This is owing to the growing prevalence of chronic diseases in the region. The strong presence of healthcare sectors in Germany, Japan and China too are accelerating the use of needle-free injectors. In the upcoming years, increasing inclination towards minimally invasive surgeries will increase the sales of needle-free injectors.

Key Takeaways from the Market Study

By load type, the projectile injections segment is expected to expand at a CAGR of 13.9% during the forecast period.
By technology, spring-loaded jet injector segment will dominate the market, holding 47.1% of the revenue share in 2022.
By application, drug delivery is expected to hold the leading share in the market, accounting for 65.0% of the revenue share in 2022.
With 79.5% of the revenue share, reusable needle-free injectors are expected to dominate the market in 2022
By end-user, hospitals are expected to be the primary end-user, accounting for over 33.4% market share during the forecast period.
US is expected to be a leading market across North America, accounting for over 94.0% of the market in 2022
Germany is expected to dominate the Europe, holding 29.4% Europe’s market share through 2032
Japan is projected to hold over 34% share in the East Asia market, exhibiting growth at a CAGR of 11.7% during the forecast period
China led the East Asia market with more than 46.8% share and is projected to expand at a CAGR of 12.0% through 2032.

“The healthcare sector along with the cosmetic industry are the largest contributors to needle-free injectors market. Increasing demand for minimally-invasive surgeries is further accelerating the demand for needle-free injectors” states an FMI analyst

Market Competition

Key players in the needle-free injectors market are Gerresheimer AG, Pfizer Inc., Antares Pharma, CSL Limited (Seqirus UK Limited), Crossject, Portal Instruments, Ferring Pharmaceuticals, PharmaJet Inc., PenJet Corporation

In August 2022, University of Adelaide began the human trail of omicron COVID vaccine booster using Pharma-Jet needle-free systems. In addition, the vaccines has been administered using PharmaJet Tropis NFIS.
Portal Instruments, a key player in the needle-free injectors market is focusing on developing needle-free injectors for different chronic ailments and creating awareness regarding painless injections.

Key Segments Profiled In The Needle-Free Injectors Market Industry Survey

Needle-Free Injectors Market by Load:

Needle-Free Injectors by Liquid Injections
Needle-Free Injectors by Powder Injections
Needle-Free Injectors by Projectile Injections

Needle-Free Injectors Market by Technology:

Needle-Free Injectors by Spring-loaded jet injector
Needle-Free Injectors by Battery-powered jet injector
Needle-Free Injectors by Gas-powered jet injector

Needle-Free Injectors Market by Delivery Site:

Needle-Free Injectors by Intra dermal injectors
Needle-Free Injectors by Intramuscular injectors
Needle-Free Injectors by Subcutaneous injectors

Needle-Free Injectors Market by Application:

Needle-Free Injectors by Drug Delivery
Needle-Free Injectors by Vaccines
Needle-Free Injectors by Cosmetic
Needle-Free Injectors by Others

Needle-Free Injectors Market by End User:

Needle-Free Injectors by Home Care Settings
Needle-Free Injectors by Long Term Care Centers

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Pelvic Floor Diagnostics Market Expected to Reach US$ 3.75 Billion by 2033, Growing at a CAGR of 6.2%

The global pelvic floor diagnostics market is projected to achieve a valuation of approximately USD 2,056.74 million in 2023, with expectations to expand to USD 3,753.39 million by the end of 2033. This growth reflects a compound annual growth rate (CAGR) of 6.2% during the forecast period.

As awareness surrounding pelvic floor disorders increases, the demand for diagnostic tools and technologies is expected to rise significantly. The pelvic floor diagnostics market is vital for improving the quality of life for individuals suffering from conditions such as incontinence and pelvic pain.

Key Highlights:

Growth in Uroflowmetry Devices and Anal Manometry Systems: The report indicates that the demand for uroflowmetry devices and anal manometry systems is anticipated to grow at an impressive CAGR of 8.2% throughout the assessment period. These devices play a crucial role in diagnosing and managing pelvic floor disorders effectively.
Rising Awareness and Education: Increasing public awareness and education about pelvic health issues are contributing to the growing demand for pelvic floor diagnostics. Healthcare providers are focusing on improving patient outcomes through early diagnosis and tailored treatment plans.
Technological Advancements: Innovations in diagnostic technologies are enhancing the precision and efficiency of pelvic floor assessments, driving market growth. Continuous advancements are expected to improve the patient experience and foster better healthcare outcomes.

The pelvic floor diagnostics market is poised for substantial growth as healthcare providers and patients alike prioritize effective management of pelvic health issues. Stakeholders, including manufacturers, healthcare professionals, and investors, have significant opportunities to engage with this expanding market.

This growth is driven by the rising prevalence of pelvic floor conditions and a growing emphasis on accurate, non-invasive diagnostic solutions. The advancement of diagnostic technologies and an increased focus on patient-centric care are fueling market expansion and innovation.

Enhancements in reimbursement structures have incentivized manufacturers to invest in the pelvic floor diagnostic sector, thereby creating a favorable environment for sustained growth through the year 2033.

Rising healthcare expenditure, along with growing government support by funding and faster approvals has led to the establishment of pelvic floor diagnostic laboratories and a larger number of professionals.

The rising number of grants by private and government players for pelvic floor diagnostics has increased the focus on innovative research solutions for the development of advanced testing systems.

Healthcare standards with advanced diagnostic procedures have gained ground during the last two decades and with the rise in income and the increased investments in research. The pelvic floor diagnostics market has experienced a substantial shift in the adoption of molecular diagnostic devices.

Key Takeaways from Pelvic Floor Diagnostics Market Study

Ultrasound systems are expected to reach a revenue share of 37.1% in 2021 with a growing CAGR of 5.7% during the forecast period.
Hospitals will drive sales accounting for over 60% of value share through 2031, owing to higher spending capacity.
Mexico will reflect a 6.1% CAGR through 2031, supported by growing access to superior medical facilities.
K. and France are leading markets in Europe, accounting for over 20% and over 18% of the Europe market respectively in 2021.
The U.S. is North America’s largest and fastest-growing market, exhibiting a 5.7% CAGR through the forecast period.

“The growing global geriatric population is prone to pelvic floor disorders. Consequently, advancements in diagnostics including imaging and ultrasound systems, coupled with investments in research and academic bodies are set to boost the growth of the pelvic floor diagnostics market over the coming decade,” says a Future Market Insights analyst.

Investments in Tech Development to Offer Growth Opportunities

The pelvic floor diagnostics market has emerged as a lucrative area of research concerning pelvic dysfunction. The development of imaging technology is gaining traction with the rising demand for high-resolution images.

The demand is fueled by increasing awareness among the growing population about the diagnostic options available. Ultrasound systems offer reliable high-resolution imaging. The evolution in the processes involving detection, diagnosis, and treatment of associated diseases is anticipated to cause a demand surge in the pelvic floor diagnostics market.

Who is winning?

Key players in the pelvic floor diagnostics market are focusing on tapping market potential through strategic mergers and acquisitions. This is driven by efficiency in innovative and specialized product portfolios. The market is also set to expand due to increasing activities in research and development to diagnose pelvic floor disorders.

Some of the leading players in the pelvic floor diagnostics market include but are not limited to Laborie, Inc., Cooper Surgical Inc., Medtronic Plc., SRS Medical, Stryker’s, MEDSPIRA, MEDKONSULT medical technology s.r.o., EndoMed Systems, Richard Wolf, Schölly Fiberoptic, Zhuhai Seesheen Medical Technology, KARL STORZ, Cadwell, The Prometheus Group, Neurosoft, Noraxon USA.

A Old Full Report Analysis Click Here

Segments:

By Product:

Urodynamics Systems
Uroflowmetry Devices
Anal Manometry Systems
Cystoscopes
Ultrasound Systems
- Cart/Trolley Based
- Portable Bladder Ultrasound Systems
EMG

By End User:

Hospitals
Diagnostic Imaging Centers
Specialty Clinics

About Future Market Insights (FMI)

Contact Us:

Wet Wipes Market Set to Nearly Double by 2033, Projected to Reach USD 9.22 Billion at a 7.8% of CAGR

The wet wipes market has generated an impressive USD 4.3 billion in revenue in 2023, with expectations for substantial growth in the coming decade. According to industry forecasts, the market is projected to expand to USD 9.22 billion by 2033, reflecting a compound annual growth rate (CAGR) of 7.8% from 2023 to 2033.

This significant growth is driven by the increasing use of wet wipes for hygiene purposes, especially in regions where access to clean water is limited. The convenience and effectiveness of wet wipes in preventing infections and maintaining cleanliness, coupled with their disposable nature, have led to a surge in consumer demand.

The wet wipes market is benefiting from a broader acceptance of these products across various applications, including personal hygiene, household cleaning, and medical use. As consumers continue to prioritize convenience and hygiene, the market is expected to see continued expansion and innovation.

Market competitors are introducing eco-friendly and biodegradable Wet Wipes produced from wood pulp and cotton as an alternative for synthetic fibres, which is driving wet wipe sales.

The rising prevalence of health-related illnesses in the elderly, such as incontinence-associated dermatitis (IAD) and catheter-associated urinary tract infection (CAUTI), is driving up demand for Wet Wipes, particularly in hospitals.

Wet Wipes are expected to gain traction over the forecast period because they efficiently serve the objective of maintaining hygiene standards and removing germs, dirt, and dust build-up on the skin and other physical surfaces.

In addition, the rise of local and small players, creative product development, clever marketing strategies implemented by top manufacturers, and commercialization of Wet Wipes are increasing the global Wet Wipes market’s growth prospects.

The FMI study projects the US to lead the North America Wet Wipes market. Rapid expansion of distribution channels, coupled with increasing per capita healthcare expenditure are anticipated to bode well for the Wet Wipes market in the U.S.

“Expansion of the ecommerce sector is resulting in easy availability and increasing sales of Wet Wipes across the globe. In addition to this, government-backed healthcare reimbursement plans will continue driving sales of Wet Wipes over the forecast period,” says the FMI analyst.

Key Takeaways:

Incontinence wipes are expected to account for roughly 27% of the worldwide Wet Wipes market share during the forecast period.
The hospital segment is expected to increase at a 6% CAGR through 2031 in terms of end users.
It is estimated that the United States accounts for more than 80% of the North American Wet Wipes market.
Germany will dominate the European Wet Wipes industry in 2021, accounting for 23% of the market.
China is expected to emerge as a profitable market, accounting for 40% of the East Asian Wet Wipes market share.
The Japanese Wet Wipes market is expected to develop at a 9.3% CAGR through 2031, while the South Korean Wet Wipes market is expected to rise at a robust 10% CAGR.

Prominent Drivers:

Collaborations among key market players to launch innovative products will provide tailwinds to Wet Wipes sales during the assessment period.

Restraints:

Availability of cheaper alternatives such as soaps, cleansing milk, and face washes might hamper sales of Wet Wipes.
Chances of allergic reactions and irritability on the skin might result in decreased sales of Wet Wipes.

Competitive Landscape

Leading players operating in the global Wet Wipes market are aiming to expand their global footprint through strategic collaborations, mergers, and acquisitions. In addition to this, launching innovative products, research, and development and strengthening distribution channels will remain key growth strategies among players. For instance:

Medline partnered with Intelligent Observation (IO) in January 2021 to help healthcare professionals manage healthcare-associated infection rates.
Essity announced the acquisition of ABIGO Medical, a wound care company, and Asaleo Care, an Australian hygiene company, in July 2021.

Leading players operating in Wet Wipes Market profiled by FMI include:

Essity Aktiebolag (publ)
Kimberly-Clark
Procter & Gamble
Cardinal Health
Medtronic
Stryker
Coloplast
Others

A Full Report Analysis Click Here

More Insights on FMI’s Wet Wipes Market

The latest market study on the Wet Wipes market by Future Market Insights gives a detailed segmentation for the forecast period of 2021 to 2031. In order to gain a better perspective of the global Wet Wipes market potential, its growth, trends, and opportunities, the market is segmented on the basis of:

Product:

Incontinence wipes
- Baby Wipes
- Adult Wipes
Skin Antiseptic Wipes
Feminine Hygiene Wipes
Skin Care Wet Wipes
Sterile Wound Cleansing Wipes

Disposability:

Flushable Wipes
Non-Flushable Wipes

Application:

Incontinence
Skincare
Personal Hygiene
Wound Care

End-User:

Hospitals
Clinics
Specialty Centers
Long term care centers
Homecare Settings

About Future Market Insights (FMI)

Contact Us:

Americas COVID-19 Testing Market Projected to Reach USD 9.8 Billion by 2033, Growing at a CAGR of 6.7%

The Americas COVID-19 testing market is currently valued at approximately USD 5.1 billion in 2023 and is expected to grow significantly, reaching an estimated USD 9.8 billion by 2033. This represents a robust compound annual growth rate (CAGR) of 6.7% throughout the forecast period.

As the world continues to navigate the impacts of the COVID-19 pandemic, the demand for testing solutions remains critical. The increase in testing capacity and the ongoing need for reliable diagnostic tools are key factors driving the growth of the COVID-19 testing market in the Americas.

Key Drivers of Market Growth:

Rising Testing Demand: With the persistence of COVID-19 variants and the importance of early detection in managing outbreaks, the demand for COVID-19 testing is expected to remain high.
Technological Advancements: Innovations in testing technologies, including rapid testing kits and molecular diagnostics, are enhancing the speed and accuracy of COVID-19 testing, further contributing to market growth.
Government Initiatives: Continued government support and initiatives aimed at increasing testing capacity and accessibility are expected to bolster the market.
Public Awareness: Heightened public awareness regarding COVID-19 testing and its role in controlling the spread of the virus is leading to increased utilization of testing services.

The Americas COVID-19 testing market presents significant opportunities for stakeholders, including manufacturers, healthcare providers, and investors, as it continues to evolve in response to the ongoing public health needs.

The market is set to expand due to frequent mutations in the virus that may lead to further outbreaks. Leading organizations within the market are set to focus on research and development to offer an early and precise diagnosis of the COVID-19, besides offering effective patient care.

To overcome the problems related to COVID-19, it is important to diagnose the ailment at an early stage of infection. According to the World Health Organization (WHO), more than 180 million positive cases of COVID-19 were diagnosed till June 2021. The rate of positive cases can be controlled with early diagnosis and treatment.

SARS-CoV-2 antigen rapid test kits are the most common type of test that accounted for value USD 2,903.0 Mn in 2020. It is widely accepted due to convenience, ease and rapid nature in the diagnosis process.

The demand for point of care testing is increasing due to advantages such as lower time requirements, at home services, and cost effectiveness. These factors are going to bolster the demand for point of care testing during the forecast period. For instance, on 28 July 2020, Roche announced the launch of the SARS-CoV-2 Rapid Antibody Test in collaboration with SD Biosensor Inc.

With the launch of vaccines and development of mass vaccination programs by governments, the number of COVID-19 cases is expected to drop by the end of 2021, however, it is expected that testing will continue even as lockdown in many countries will be lifted. Key players are focused on strengthening their mergers and acquisitions with new discoveries of technologies.

Key Takeaways from COVID-19 Testing Services Market Study

SARS-CoV-2 antigen rapid test kits are expected to account for over 67% the Americas COVID-19 testing market share by 2031, owing to higher efficacy in diagnostics.
Hospital pharmacies accounted for more than 32% of the market share in 2021. The soaring influx of patients for treatment and intensive care support has driven growth.
Canada will reflect relatively steady growth with a 4.8% CAGR, driven by the matured, government funded healthcare system.
The U.S. will reflect fast growth at a CAGR around 5.7% through 2021-2031. U.S. holds the lead owing to, high healthcare expenditure, and the presence of leading players.
Brazil is the leading country in Latin America, estimated to account for about 54% of the regional share in 2021, supported by easier access to required technologies.

“The shift in focus from testing to vaccination is expected to hamper market growth in the near future. However, the focus on testing for international travel, frequent testing of medical staff and testing for patients with flu like symptoms are expected to continue aiding market growth,” says the Future Market Insight analyst.

Want More Insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global COVID-19 testing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the COVID-19 testing treatment market on basis of the test type in detail, cover every aspect of the market such as Test type, sample type, distribution channel across North America and Latin America region.

Americas COVID-19 testing Market by CategoryTest Type:

SARS-CoV-2 IgM/IgG Antibody Rapid Test Kits
SARS-CoV-2 Antigen Rapid Test Kits
Multiplex Real-Time RT-PCR Assay Kits

Sample Type:

Blood
Nasopharyngeal Swabs

Distribution Channel:

Hospital Pharmacies
Diagnostic Laboratories
Retail Pharmacies
Drug Store
Online Sales Channels

Region:

North America
Latin America

About Future Market Insights (FMI)

Contact Us:

Multilayer Transparent Conductors Market: Projected to Surge at a 10.3% CAGR, Eyeing US$ 13,285.2 Million by 2032

The global multilayer transparent conductors market was worth US$ 4999.1 million in the year 2022 and is expected to reach US$ 13,285.2 million by the year 2032 at a notable CAGR of 10.3% between 2022 and 2032.

Growing demand for electronic appliances (smartphones in particular) is the factor accelerating the multiplayer transparent conductors market. Also, materials needed to manufacture multiplayer transparent conductors are cost-effective and render better results. Besides, the fact that the majority of end-users are harping on emphasizing environmentally friendly and sustainable products can’t be ignored. With solar energy being the cornerstone, the cost of nanotube films is reducing.

The key players are in collaboration with advanced and computational microscopy groups apart from educational institutions to improve zinc tin oxide’s optoelectronic properties by passivating sub-gap atomic-scale defects. They are trying out the other materials on this count.

At the same time, there is a dearth of skilled laborers in the multilayer transparent conductors market, especially when it comes to low-income regions. This factor may restrain the multilayer transparent conductors market shortly. Plus, the fragility of items is another factor to ponder.

Future Market Insights has entailed the facets with future prospects in its latest market study entitled ‘Multilayer Transparent Conductors Market’. It has a team of analysts and consultants to look through a bottom-up approach in its primary, secondary, and tertiary modes of research.

Key Takeaways From The Multilayer Transparent Conductors Market Report:

North America holds the largest market share due to rising demand for several displays of transparent conductors for smartphones, and eyeglasses in the US.
Europe holds the second-largest market share on similar grounds.
The Asia-Pacific is expected to grow on the quickest note in the forecast period with India, China, and Japan leading from the front.

Competitive Conductors:
The key participants mentioned below are in development of the advanced materials for bringing down the price involved in making multilayer transparent conductors.

Leading Key Players:

3M Company
Canatu Oy
Nitto Denko Corporation
DuPont Teijin Films
Toyobo Corporation
Fujifilm Holdings Corporation
Thin Film Devices Inc.
DONTECH Inc.
Abrisa Technologies
Eastman Kodak
Acree Technologies Inc.
Cambrios Technologies Corporation
Apple Inc.
Quantum Coating Inc.
Cima Nanotech

Lead With Data-Driven Decisions. Buy Now To Turn Insights Into Competitive
https://www.futuremarketinsights.com/checkout/4366

What does the Report say?

The research study is based on type (ITO (Indium Tin Oxide Thin Films), carbon nanotubes films, nano-silver based transparent conductors, metal grids, and conductive polymers), by material (ITO on glass, carbon nanotubes, silver nanowires, metal mesh, and likewise), and by application (Liquid Crystal Displays, OLEDs (Organic Light Emitting Diodes), touchscreen sensors, flat panel displays, photovoltaics, solar cells, flexible electronics, smart windows, and optical coatings).
With multilayer transparent conductors witnessing higher demand for specialized applications, the global multilayer transparent conductors market is expected to grow on a good note in the forecast period.

Multilayer Transparent Conductors Market Segmentation:

By Type:

Indium tin oxide thin films (ITO)
Carbon nanotubes films
Nano-silver based Transparent conductors
Metal grids
Conductive polymers

By Material:

ITO on Glass
Carbon Nanotubes
Silver Nanowires
Metal Mesh
Others

By Application:

Liquid-crystal displays
Organic light-emitting diodes (OLEDs)
Touchscreen sensors
Flat panel displays
Photovoltaics
Solar cells
Flexible electronics
Smart windows
Optical coatings

Request for a Sample of this Research Report
https://www.futuremarketinsights.com/reports/sample/rep-gb-4366

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Multichannel Networks Market Growth Factors, Opportunities, Ongoing Trends and Key Players 2032

During the forecast period, the multichannel networks market is expected to grow at a CAGR of 12.8% globally. The multichannel networks market is projected to transcend US$ 14,547.7 Mn by 2032 and reach a market worth US$ 4,363.5 Mn in 2022.

Internet users’ increased use of video platforms has given multichannel networks new opportunities to provide video content services like cross-promotion, sponsorship, audience engagement, etc., which help multichannel networks generate income from the YouTube platform. With the help of multichannel networks, video material may be optimized in a variety of ways to boost viewer engagement on YouTube channels. Portfolio diversification enables MCNs to move away from managing content and brands and towards generating money from the current website traffic.

There are several benefits to content creators in doing the partnership with multichannel networks and video platforms which include video creation and publishing tools, higher CPM, production and editing facilities, marketing and promotion, live events & merchandise, and copyrights and licenses for videos.

Multichannel networks aggregate thousands of channels with YouTube to syndicate, monetize, and manage content. Some multichannel networks have also started to produce their original content. In general, YouTube is the only platform used by most multichannel networks except their websites, which feature similar video content.

Multichannel Networks Market: Market Dynamics

It has been observed that most of the Multichannel networks are entering into partnership with advertisers to provide them a platform for advertisement where most of the internet users spent their time. Therefore, it can be concluded that increasing usage of the internet on mobile and standalone devices rise the demand for multichannel networks.

The increase in consumption of online and mobile video owing to platform diversification and the rise in business on YouTube due to the growing number of content creators are the drivers for the multichannel networks market.

Higher investment, rise in cyber security threats and complexity in integration on video platforms are the restraints of the multichannel networks market.

Segmentation Overview

The Multichannel Networks market is segmented into services and tools, applications, and regions. By services and tools, multichannel networks market segmented into production & editing tools, funding, monetization assistance, cross-promotion, and digital rights management. Based on application, the multichannel networks market is segmented into telecommunication, media & entertainment, BFSI, TV broadcasting, and Information technology.

Global Multichannel Networks Market: Competition Landscape

Few prominent players in Multichannel Networks market include Machinima, Inc., Maker Studios, Inc., Fullscreen, Inc., Culture Machine Media Pvt. Ltd, Qyuki Digital Media Private Limited, Vevo LLC, ZEFR, Inc., Warner Music, Inc., Universal Music Group, Inc., Warner Bros. Entertainment Inc., and The Orchard Enterprises, Inc.

Multichannel Networks Market: Regional Outlook

North America is expected to hold the largest share in multichannel followed by APEJ, Western Europe, and MEA regions. Due to the increase in online video consumption and digital transformation, there is significant growth in the multichannel networks market in the forecast period

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also includes projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geography, technology, and applications.

The report covers an exhaustive analysis on

Global Multichannel NetworksMarket Segments
Global Multichannel NetworksMarket Dynamics
Historical Actual Market Size, 2012 – 2016
Global Multichannel NetworksMarket Size & Forecast 2016 to 2027
Supply & Demand Value Chain for Multichannel NetworksMarket
Global Multichannel NetworksMarket Current Trends/Issues/Challenges
Competition & Companies involved in Multichannel NetworksMarket
Multichannel NetworksTechnology
Value Chain of Multichannel Networks
Global Multichannel NetworksMarket Drivers and Restraints

Regional analysis for Global Multichannel Networks Market includes

North America Multichannel NetworksMarket
US & Canada
Latin America Multichannel NetworksMarket
Brazil, Argentina & Others
Eastern Europe Multichannel NetworksMarket
Poland
Russia
Rest of Eastern Europe
Western Europe Multichannel NetworksMarket
Germany
Italy
France
UK
Spain
Nordic
BENELUX
Rest of Western Europe
Asia Pacific Multichannel NetworksMarket
Australia and New Zealand (ANZ)
Greater China
India
ASIAN
Rest of Asia Pacific
Japan Multichannel NetworksMarket
Middle East and Africa Multichannel NetworksMarket
GCC Countries
Other Middle East
North Africa
South Africa
Other Africa

Request a Sample of This Report

About Future Market Insights (FMI)

Contact Us:

Ocular Drug Delivery System Market Expected to Reach USD 16,159.9 Million in 2023, Projected to Surge at a CAGR of 6.9% Through 2033

The ocular drug delivery system market is on track to surpass USD 16,159.9 million in 2023, driven by an increasing prevalence of ophthalmic diseases and a growing emphasis on advanced treatment solutions. According to Future Market Insights, the market is expected to experience robust growth at a compound annual growth rate (CAGR) of 6.9% from 2023 to 2033.

By 2033, the market is projected to achieve a valuation of USD 31,410.2 million. Particulate drug delivery systems are anticipated to lead demand, expected to account for over 70% of the global market in 2023. This surge in market size reflects the ongoing advancements and heightened focus on effective ocular treatments.

A significant factor contributing to this growth is the high demand for particulate drug delivery systems, which are anticipated to dominate the market, accounting for over 70% of global sales in 2023. These systems are favored for their effectiveness in delivering targeted therapies to the ocular region.

To overcome the ocular drug delivery barriers and improve ocular bioavailability, various conventional and novel drug delivery systems have been developed such as ointments, emulsions, suspensions, aqueous gels, Nano micelles, liposomes, and in situ thermosensitive gels for the earlier mentioned ocular diseases.

Glaucoma is the second-leading cause of blindness worldwide, accounting for up to 8% of total blindness. In India, glaucoma is the leading cause of irreversible blindness with at least 12 million people affected and nearly 1.2 million people blind from the disease. More than 90 percent of glaucoma cases remain undiagnosed in the community.

Thus the high incidence of ophthalmic diseases, resulting in the rise significant patient population, is driving the global ocular drug delivery systems market.

The ocular drug has to pass the water-fat-water membranous structure of the cornea and this changing environment presents a significant barrier. That is why, for almost four decades, researchers have been involved in developing intraocular sustained-release drug delivery platforms.

Owing to the rigorous research studies, approvals for new ocular drug delivery techniques are currently recorded globally. This has helped the market to gain momentum over the last few years.

Key Takeaways from Global Ocular Drug Delivery System Industry Study

Increasing focus on pharmaceutical innovation and research on drug delivery technologies is driving a transition towards particulate drug delivery systems, which will account for over 68% of the market in 2021.
Ophthalmic solution for ocular drug delivery systems is expected to account for 60% of the global market share by 2031.
Among distribution channels, hospital pharmacies accounted for 40% of the market share in 2031. The soaring influx of patients for treatment and the availability of intensive care support has propelled the demand in the segment.
North America holds the maximum share, owing to the presence of Tier 1 players, high per-capita healthcare expenditure, and favorable reimbursement policies in the region.
The U.S. holds a more than 44% share in the global ocular drug delivery systems market.
The U.K. and Germany are leading markets in Europe, accounting for more than 41% of the Europe market in 2021.
South Korea is the fastest-growing market in East Asia, exhibiting a 10.3% CAGR through 2031.

“Increasing prevalence of eye infections, innovation in drug delivery technologies, and rising clinical trials are creating lucrative growth opportunities for ocular drug delivery system sales,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).

Increase in Funding for Research Activities Offers Growth Opportunities

Leading manufacturers in the Global Ocular Drug Delivery System Industry are strengthening their market position through collaboration with various other organizations. Governments in developed and developing countries are actively taking initiatives to encourage research of pharmaceutical products.

For instance, In April 2017, Santen Pharmaceuticals announced a strategic investment in Regenerative Patch Technologies LLC, a U.S.-based company engaged in the development of ophthalmic therapies.

Pharmaceutical giants are expected to benefit from the globalization of labor forces, that is, the employment of skilled local labor at cheaper rates to derive larger cost savings. Furthermore, this will create room for research and development (R&D) investments.

As per data from EFPIA and PhRMA, annual pharmaceutical (R&D) expenditures increased at 2.5% p.a. in Europe as compared to 3.3% p.a. in the U.S. over the latest measurable period 2016-2020. This will also create opportunities for the expansion of the market.

Who is Winning?

The global market is set to expand due to the rising prevalence of eye infections. Leading players within this space are expected to focus on research and development to offer an early and precise diagnosis of ailment, besides offering effective patient care.

Some of the leading players in the Global Ocular Drug Delivery System Industry include but are not limited to Allergan Plc., Graybug Vision Inc., Ocular Therapeutix, Inc., Alimera Sciences, pSivida, Santen Pharmaceutical Co., Ltd, Taiwan Liposome Company Ltd., Envisia Therapeutics, Eyegate Pharma, Valeant Pharmaceuticals International, Inc, Vision Ophthalmology Group GmbH, Clearside Biomedical, URSAPHARM Arzneimittel GmbH.

Want More Insights?

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global ocular drug delivery systems market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights into the ocular drug delivery systems treatment based on the key indication in detail, covering every aspect of the market such as technology, dosage form, and distribution channel across seven major regions.

A Full Report Analysis Click Here

Ocular Drug Delivery Systems Market by Category

By Technology:

Implantable
Particulate
Nanoparticle

By Dosage Form:

Ophthalmic Solution
Ophthalmic Suspension
Ophthalmic Emulsion
Ophthalmic Gels
Ophthalmic Ointments

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Drug Store
Mail Order Pharmacies

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us: